Phillip Horwitz is a Cardiology physician affiliated with University of Iowa. OpenAlex indexes 94 publications with 3,066 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.2%Beta blocker17.9%Metoprolol Tartrate59%Metoprolol Succinate42%Part D≥19 patientsStatin12.7%Atorvastatin Calcium71%Rosuvastatin Calcium15%Simvastatin15%Part D<11 patients+ 6 more classes in this area
Blood & clotting
20.8%P2Y12 inhibitor15.2%Clopidogrel100%Part D≥24 patientsFactor Xa inhibitor5.6%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
9%Potassium supplement5.4%Potassium Chloride100%Part D<11 patientsProton pump inhibitor3.6%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2007 per NIH RePORTER. The latest:
- TRIUMPH (TRANSLATIONAL RESEARCH INVESTIGATING UNDERLYING MYOCARDIAL INFARCTION)
University of Iowa
FY2007$612M01RR000059
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
European Heart Journal - Cardiovascular Pharmacotherapy
2024 - Impact of on-pump and off-pump coronary artery bypass grafting on 10-year mortality versus percutaneous coronary intervention
European Journal of Cardio-Thoracic Surgery
2023 - Incidence and severity of thrombocytopenia associated with use of intravascular microaxial ventricular assist devices for treatment of cardiogenic shock
Catheterization and Cardiovascular Interventions
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mohammed Milhem, MBBS
University of Iowa
Lawrence Hunsicker, MD
University of Iowa
Michael Abramoff, MD, PhD
University of Iowa
William Coryell, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”